beta-cell function in normal rats made chronically hyperleptinemic by adenovirus-leptin gene therapy

Area of Science:

• Metabolic Research
• Endocrinology
• Molecular Biology

Background:

• Leptin, a hormone primarily produced by adipose tissue, regulates energy balance and appetite.
• Dysregulation of leptin signaling is implicated in metabolic disorders such as obesity and diabetes.
• The precise mechanisms by which leptin influences pancreatic beta-cell function remain incompletely understood.

Purpose of the Study:

• To investigate the effects of sustained hyperleptinemia on Wistar rat metabolism and pancreatic beta-cell function.
• To elucidate the role of tissue lipids in mediating leptin-induced changes in insulin secretion.

Main Methods:

• Overexpression of leptin in Wistar rats using recombinant adenovirus.
• Measurement of plasma leptin, insulin, body weight, and food intake.
• Assessment of pancreatic islet function via perifusion studies with glucose and arginine, and analysis of islet triglyceride content.
• In vitro studies involving leptin treatment of isolated islets and subsequent perifusion with fatty acids.

Main Results:

• Adenovirus-mediated leptin overexpression led to decreased food intake, body weight, and visible fat.
• Hyperleptinemia resulted in hypoglycemia and reduced plasma insulin levels, indicating enhanced insulin sensitivity.
• Pancreatic islets showed depleted triglyceride content and impaired insulin response to glucose and arginine, which was restored by fatty acid co-perfusion.
• In vitro leptin exposure similarly depleted islet triglycerides and impaired insulin secretion, reversible by fatty acids.

Conclusions:

• Sustained hyperleptinemia in normal rats induces reversible beta-cell dysfunction.
• This dysfunction is attributed to the depletion of tissue lipids within beta-cells, disrupting lipid-derived signaling necessary for fuel-stimulated insulin release.
• Lipid availability is crucial for maintaining normal beta-cell responsiveness to metabolic stimuli.